The formation of functional neural circuits in the vertebrate central nervous system (CNS) requires that appropriate numbers of the correct types of neuronal and glial cells are generated in their proper places and times during development. In the embryonic CNS, multipotent progenitor cells first acquire regional identities, and then undergo precisely choreographed temporal identity transitions (i.e. time-dependent changes in their identity) that determine how many neuronal and glial cells of each type they will generate. Transcription factors of the basic-helix-loop-helix (bHLH) family have emerged as key determinants of neural cell fate specification and differentiation, ensuring that appropriate numbers of specific neuronal and glial cell types are produced. Recent studies have further revealed that the functions of these bHLH factors are strictly regulated. Given their essential developmental roles, it is not surprising that bHLH mutations and de-regulated expression are associated with various neurological diseases and cancers. Moreover, the powerful ability of bHLH factors to direct neuronal and glial cell fate specification and differentiation has been exploited in the relatively new field of cellular reprogramming, in which pluripotent stem cells or somatic stem cells are converted to neural lineages, often with a transcription factor-based lineage conversion strategy that includes one or more of the bHLH genes. These concepts are reviewed herein.
Introduction
The vertebrate central nervous system (CNS) is comprised of a diverse array of neuronal and glial (astrocytes and oligodendrocytes) cell types that together make up functional brain regions that connect in a complex manner to allow for higher order cognitive functioning and sensory processing. Understanding how neural cells acquire their precise phenotypes is key to understanding brain function in normal and diseased states, and to deciphering new strategies to generate exogenous sources of neural cells for cellular repair. Members of the basic-helix-loop-helix (bHLH) family of transcription factors have emerged as essential regulators of neural cell fate specification and differentiation during embryonic development and in regions of the adult neural tube where neural stem cell (NSC) niches are maintained throughout life. Moreover, their differentiation properties have been exploited in the relatively new field of neural cell reprogramming. Indeed, one or more of these bHLH genes are included in many of the current transcription factorbased lineage neuronal conversion strategies. Here we focus on the roles of the bHLH genes in the developing CNS, describing their region-specific functions in the neural tube, and their transcriptional, post-transcriptional and post-translational regulation. We also cover associations between bHLH genes and disease, and finally, describe their central roles in neural cell reprogramming.
Due to space limitations, this review primarily focuses on murine bHLH genes, with studies in invertebrates, fish, frogs and humans only mentioned when comparisons are particularly insightful. Furthermore, due to length restrictions, we do not cover bHLH function in adult NSC niches, nor review the Hes/Hey genes, which are bHLH genes that are downstream effectors of Notch signaling.
A primer on bHLH transcription factors
2.1. bHLH structure and function bHLH transcription factors are named based on their protein structure. The HLH domain is comprised of two alpha-helices connected by a non-conserved loop region and is used for dimerization, whereas the basic domain directs DNA binding ( Fig. 1 ; reviewed in (Bertrand et al., 2002) ). After dimerization, bHLH transcription factors bind E-box motifs with the consensus sequence CANNTG, with the central two nucleotides, as well as surrounding nucleotides, providing specificity of binding (reviewed in (Bertrand et al., 2002) ).bHLH transcription factors can be broadly classified based on their patterns of expression as either class I or class II. Class I bHLH proteins are ubiquitously expressed, and are encoded by Tcfe2a (E12, E47), Tcf4, and Tcf12 (Meredith and Johnson, 2000; Sun and Baltimore, 1991) . Class II bHLH factors have tissue-specific expression profiles (reviewed in (Bertrand et al., 2002) ) and are involved in a diverse array of developmental processes, including myogenesis (reviewed in (Berkes and Tapscott, 2005; Rudnicki et al., 2008) ), fly sex determination (reviewed in (Garrell and Campuzano, 1991; Parkhurst and Meneely, 1994) ), and haematopoiesis (reviewed in (Bloor et al., 2002; Curtis et al., 2012) ). Herein, we focus on the class II bHLH transcription factors that are expressed and function in the developing nervous system. Neural-specific bHLH genes are subdivided based on their homology to Drosophila genes that are expressed in the nervous system, including the achaete-scute complex (AS-C) (achaete, scute, lethal of scute) and atonal (atonal, amos, cato) gene families (Bertrand et al., 2002; Garcia-Bellido and Moscoso del Pradio, 1979; Jarman et al., 1994; Villares and Cabrera, 1987) . There is a single murine achaete-scute like 1 (Ascl1/Mash1) gene that is expressed in the nervous system, as well as the more distantly related Nscl family genes (Nhlh1/Nscl1, Nhlh2/Nscl2). In contrast, there are multiple atonal-related bHLH genes that are expressed in neural lineages, including members of the Neurogenin (Neurog1, Neurog2, Neurog3), Neurod (Neurod1, Neurod2/Ndrf, Neurod6/Math2, Neurod4/Math3), Atonal (Atoh1/Math1, Atoh7/Math5) and Olig (Olig1, Olig2, Olig3, Bhlhe22/Bhlhb5) families. While these subdivisions are based on sequence similarities, these genes can also be grouped based on functional properties into proneural and neural (neuronal or glial) differentiation genes.
Proneural bHLH genes
Proneural bHLH transcription factors include a smaller subset of the neural-specific bHLH genes. In Drosophila, proneural genes in the AS-C and atonal families are expressed in uncommitted ectodermal cells, conferring a neural identity onto these cells, whereas in vertebrates, proneural genes are expressed after neural determination has occurred, in cells that have already acquired a neural identity. Despite these differences, proneural genes function similarly in flies and vertebrates, and in both species, they are necessary and sufficient to promote neuronal differentiation and to specify neuronal subtype identities (reviewed in (Bertrand et al., 2002; Guillemot and Hassan, 2017) ). Moreover, in both invertebrates and vertebrates, proneural genes are characterized by their ability to induce Notch signaling, specifically the expression of Delta ligands, such as Dll1 and Dll3. Finally, at a functional level, the loss of proneural gene function results in fewer neurons being born, while the gain of proneural gene function results in the generation of supernumerary neuronal cells.
Based on these strict definitions, the murine neural-specific bHLH genes with proneural activity include Neurog1, Neurog2, Ascl1, Neurod4, Atoh1 and Atoh7. Both Neurog1 (Ma et al., 1998) and Neurog2 (Fode et al., 1998) were initially shown to have proneural activity in the peripheral nervous system (PNS), directing the differentiation of cranial ganglia neurons. Subsequent studies revealed that Neurog2 also has proneural activity in the CNS, including in the neocortex (Fode et al., 2000) , where it directs a neuronal fate while repressing a glial identity (Nieto et al., 2001) , and in the spinal cord (Scardigli et al., 2001) . Ascl1 was first defined as a proneural gene in the PNS, including in the olfactory epithelium and autonomic nervous system (Guillemot et al., 1993) , followed by the demonstration of its proneural properties in the ventral telencephalon (Casarosa et al., 1999; Horton et al., 1999) . Neurod4 was first characterized as a proneural gene in the tectum, where it acts in a redundant manner with Ascl1 to promote neurogenesis while inhibiting gliogenesis (Tomita et al., 2000) . Within the Atonal family, Atoh1 was initially shown to function as a proneural gene in the cerebellum, where it directs the differentiation of granule neurons (Ben-Arie et al., 1997) , and then later in the PNS, where it directs the differentiation of inner ear hair cells (Bermingham et al., 1999) . Finally, Atoh7 proneural activity was defined in the retina based on its requirement to direct the differentiation of retinal ganglion cells (Brown et al., 2001; Wang et al., 2001 ).
Differentiation bHLH genes
Several bHLH genes are expressed and function later in the development of neural lineages -either in committed neuronal/ glial precursors or in postmitotic neuronal and glial cells. The genes that play important roles in neuronal and glial differentiation and maturation include members of the NeuroD (Neurod1, Neurod2/ Ndrf, Neurod6/Math2), Nscl (Nhlh1/Nscl1, Nhlh2/Nscl2), and Olig (Olig1, Olig2, Olig3, Bhlhe22) families. These genes are widely expressed in distinct subsets of postmitotic neuronal and glial cells in different regions of the neural tube. For example, Neurod1 is required for the differentiation of inner ear sensory neurons (Kim et al., 2001; Liu et al., 2000a) and granule cells in the cerebellum (Miyata et al., 1999) and hippocampus (Liu et al., 2000b; Schwab et al., 2000) . Neurod2 and Neurod6 are together required for the formation of callosal connections in the cerebral cortex (Bormuth et al., 2013) . In the retina, Neurod1 is required for photoreceptor survival (Cho et al., 2007; Ochocinska et al., 2012) , Neurod2 is necessary for the differentiation of AII amacrine cells (Cherry et al., 2011) , and Neurod6 is required for the differentiation of non-GABAergic/non-glycinergic amacrine cells (Kay et al., 2011) . Neurod6 also cooperates with Neurod1 for the differentiation of midbrain dopaminergic neurons (Khan et al., 2017) , and for the terminal differentiation of hippocampal granule neurons (Schwab et al., 2000) , whereas Neurod2 is required to regulate the excitability of cortical pyramidal neurons (Chen et al., 2016) . In the Nsc1 bHLH family, Nhlh1 and Nhlh2 are required for the formation of pre-cerebellar neurons in the hindbrain (Schmid et al., 2007) . Finally, of the Olig family bHLH genes, Bhlhe22 is required for the differentiation of neurons in several CNS domains, including the dorsal horn of the spinal cord (Ross et al., 2010) , dorsal cochlear nucleus in the brainstem (Cai et al., 2016) and retinal amacrine cells (Feng et al., 2006) .
Unlike the neuronal differentiation genes, Olig1 and Olig2 are best characterized for their roles in promoting glial, and more specifically, oligodendrocyte differentiation. Olig1 was first shown to be necessary and sufficient to promote an oligodendrocyte fate in the embryonic neocortex (Lu et al., 2001a) , whereas Olig2 was first shown to be necessary (Takebayashi et al., 2002) and sufficient (Zhou et al., 2001 ) to promote oligodendrocyte differentiation in the spinal cord. In contrast, Olig3 has been best characterized as a neuronal differentiation gene, controlling the differentiation of pre-cerebellar neurons (Liu et al., 2008) , brainstem nuclei (Storm et al., 2009) , and dorsal spinal cord neurons (Muller et al., 2005) . 
Overview
A major question for neurodevelopmental biologists is how distinct types of neuronal and glial cells are generated in different regions of the neural tube, especially when the same bHLH factors are often re-used or 're-purposed' in multiple CNS domains. We provide here an overview of how neuronal fates are specified by bHLH genes in various CNS domains, including the dorsal and ventral telencephalon, spinal cord, retina and hindbrain, with the goal of highlighting similarities and differences in proneural gene function in these domains.
bHLH gene function in the dorsal telencephalon
The dorsal telencephalon is the embryonic anlage of the neocortex, which, at maturity, is a six-layered neuronal structure. During embryogenesis, neocortical neurons are derived from cortical progenitor cells in the ventricular zone (VZ) and subventricular zone (SVZ) of the dorsal telencephalon ( Fig. 2A) . These progenitors give rise to glutamatergic pyramidal neurons between embryonic day (E) 10.5 and E17.0 in mouse (Takahashi et al., 1999) , followed by the differentiation of astrocytes in late embryogenesis, and oligodendrocytes in the early postnatal period (Kessaris et al., 2006) . The earliest-born neurons are the Cajal-Retzius neurons, which arise between E10.5 and E12.5 from progenitor domains in the pallial margins, including the ventral pallium, cortical hem and pallial septum (Bielle et al., 2005) . Cajal-Retzius neurons form the marginal zone, which is layer I of the neocortex. Subplate neurons, which form a transient layer VII in most species, are generated next, at E11.5, and settle beneath the marginal zone (Takahashi et al., 1999) . Together the marginal zone and subplate merge to form a preplate layer of neurons. As layer VI neurons differentiate, at $E12.5, they migrate into the center of the preplate to separate it into an overlying marginal zone and underlying subplate (Takahashi et al., 1999) . The remaining neuronal layers are generated in a sequential, inside-out fashion, with layer V neurons differentiating next and migrating past layer VI neurons to settle in a more superficial position, followed by the differentiation and migration of layer IV and finally, layer II/III (fused in mouse) neurons (Caviness et al., 1995) .
Neurog1. and Neurog2 are expressed in cortical (or pallial) progenitors in the VZ, and to a lesser extent in the SVZ, of the dorsal telencephalon beginning at the onset of neurogenesis, with Neurog2 expressed throughout neurogenesis (E10.5-E17) and beyond, while Neurog1 expression declines after E15.5 (Dixit et al., 2014b; Fode et al., 2000; Schuurmans et al., 2004) . Spatially, Neurog1 transcripts are more abundant in lateral domains, whereas Neurog2 transcripts are distributed throughout the VZ. In loss-offunction studies, Neurog2 is required for the genesis of a subset of the earliest-born Cajal-Retzius neurons (Dixit et al., 2014b) . Interestingly, while fewer Cajal-Retzius neurons are generated in Neurog2 À/À cortices, more of these early-born neurons are generated in Neurog1 À/À cortices (Dixit et al., 2014b; Fode et al., 2000; Mattar et al., 2004) . A possible reason is that Neurog1 is required to limit the proneural activity of Neurog2, such that in the absence of Neurog1, Neurog2 has enhanced proneural activity, and can promote the differentiation of more Cajal-Retzius neurons (CS, DD, data not shown; (Dixit et al., 2014b) ). In contrast, in the lateral piriform cortex, these two genes are required together to generate lot1 + Cajal-Retzius neurons, which are not present in Neurog1
Neurog2
À/À cortices (Dixit et al., 2014b) .
The next cells to differentiate in the neocortex are the subplate neurons, which are reduced in number and disrupted in organization in the absence of Neurog2 function (Mattar et al., 2004) . The subplate is disrupted in Neurog2 À/À cortices in part because Ascl1 is upregulated, which leads to the misspecification of early-born (birth before E14.5) neurons to an aberrant GABAergic identity (Fode et al., 2000; Schuurmans et al., 2004) . Notably, Neurog2 forms a genetic switch with Ascl1, such that when Neurog2 is turned off, Ascl1 expression is turned on (Fode et al., 2000; Schuurmans et al., 2004) . The upregulation of Ascl1 results in the generation of ectopic GABAergic interneurons (Fode et al., 2000; Schuurmans et al., 2004) , as well as oligodendrocyte precursor cells (OPCs) (Parras et al., 2007) . Not only are Neurog1 and Neurog2 both required for the expression of markers of a dorsal regional identity and glutamatergic neurotransmitter phenotype in the embryonic neocortex, they are also sufficient to induce this phenotype (Fode et al., 2000; Mattar et al., 2008; Parras et al., 2002; Schuurmans et al., 2004) , at least when misexpressed before E14.5 (Dennis et al., 2017; Li et al., 2012) . Before E14.5, Neurog2 can induce the expression of most NeuroD and Nscl1 family genes in cortical and subcortical progenitors, all of which are expressed in subsets of glutamatergic neurons in the embryonic neocortex (Mattar et al., 2008) . After E14.5, Neurog2 activity is tightly regulated, as discussed further below.
Neurog1 can similarly promote neurogenesis in early cortical progenitors, but these gain-of-function studies have only been performed at E10.5 (Dixit et al., 2014b) , so it is not clear whether there are similar temporal restrictions on Neurog1 activity. In addition to promoting neurogenesis, Neurog1 represses glial fates in two ways. First, Neurog1 protein sequesters CBP-Smad1-Stat3 transcriptional complexes away from the regulatory regions of genes involved in astrogliogenesis (Sun et al., 2001) . Second, Neurog1 activates the expression of miR-9, a micro RNA that targets components of the Jak-Stat pathway, including Lifr-beta, Gp130, and Jak1 (Zhao et al., 2015) . While structurally similar to Neurog1, a role in gliogenic repression by Neurog2 has not yet been shown.
In addition to regulating neuronal differentiation and subtype specification, Neurog1 and Neurog2 are also required for the proper migration of neocortical neurons, especially early-born deep-layer neurons (Schuurmans et al., 2004 ). An important Neurog2 residue that regulates the polarity of the leading process during neuronal migration is Y241, the phosphorylation of which is required to inhibit RhoA activity (Ge et al., 2006; Hand et al., 2005) . To mediate the inhibition of RhoA, Neurog2 induces the transcription of Rnd2, a small GTP-binding protein (Heng et al., 2008) .
There is also evidence that Neurog2 regulates axonal projection patterns in the neocortex, as thalamocortical axons (Seibt et al., 2003) , which target the subplate, corticofugal axons (Dennis et al., 2017; Hand and Polleux, 2011; Schuurmans et al., 2004) , which project subcortically from layers VI and V, and callosal axons, which target the midline (Hand and Polleux, 2011) , are all disrupted in Neurog2 À/À cortices. Moreover, misexpression of Neurog2 can confer a subcortical projection pattern onto newborn neurons even when expressed outside of the normal window of their birth (i.e., after E14.5), even though these ectopic neurons do not express normal deep-layer markers (Dennis et al., 2017) .
Ascl1
Ascl1. is expressed in a limited number of cortical progenitors in the VZ and SVZ compared to its robust expression in the ventral telencephalon (as discussed below) (Britz et al., 2006) . In the developing neocortex, similar to Neurog2, Ascl1 is required for the differentiation of a subset of early-born, glutamatergic Cajal-Retzius neurons (Dixit et al., 2011) . At later stages, when cortical plate neurons are differentiating, Ascl1 controls radial migration by regulating the expression of Rnd3, which similar to Rnd2, is a small GTP-binding protein that inhibits RhoA (Pacary et al., 2011) .
Ascl1 also functions in a redundant manner with Neurog2 to control laminar fate specification via input into the cortical derepression circuit (Dennis et al., 2017) . Neurog2 and Ascl1 are required together to turn off the expression of Tbr1, a layer VI marker, in upper layer neurons, which should not express this gene. Neurog2 and Ascl1 are also both required and sufficient for the generation of Ctip2 + layer V neurons, which are lost in Neurog2 (Dennis et al., 2017) . Finally, Neurog2 and Ascl1 are both required to repress the expression of Satb2, a marker of late-born upper layer neurons that are generated precociously in Neurog2 (Dennis et al., 2017) . Notably, there is also precocious gliogenesis in Neurog2
; Ascl1 À/À cortices, suggesting that these two proneural genes are required together to control the timing of neural cell differentiation (Nieto et al., 2001 ). In addition, Neurog2 and Ascl1 also cooperate in the guidance of callosal axons to the midline, and while the corpus callosum does not form in Ascl1 À/À mutants, likely due to defects in the formation of midline glia that serve as guideposts for these axons (Casarosa et al., 1999; Dennis et al., 2017) , axonal targeting to the midline is much more disrupted in Neurog2
tices (Dennis et al., 2017) . Finally, at early postnatal stages, Ascl1 is involved in the specification of an OPC fate in cortical progenitors (Nakatani et al., 2013) , akin to its function in embryonic progenitors in the ventral telencephalon (see below).
bHLH gene function in the ventral telencephalon
At early embryonic stages ($E12.5), the ventral telencephalon is divided into the lateral (LGE), medial (MGE) and caudal (CGE) ganglionic eminences ( Fig. 2A) , all of which give rise to distinct populations of GABAergic neurons (reviewed in (Laclef and Metin, 2017) ). These progenitor domains give rise to projection neurons that remain in the ventral telencephalon, populating the globus pallidus, amygdala and septum (MGE, CGE), and striatum (LGE, CGE) (Laclef and Metin, 2017) . In addition, ventrally derived neurons migrate tangentially to dorsal domains of the telencephalon, with the MGE and CGE contributing to neocortical and hippocampal GABAergic interneurons, and the LGE giving rise to interneurons that populate the olfactory bulb (Laclef and Metin, 2017) . Neuronal differentiation in this region of the brain occurs earlier than in dorsal domains, with the MGE giving rise to most neurons between E10.5 and E14.5, and migration beginning at $E12.5 (Laclef and Metin, 2017) .
The only proneural bHLH gene expressed in the ventral telencephalon is Ascl1, transcripts for which are found in subcortical (or subpallial) progenitors in the VZ and SVZ of the LGE, MGE, and CGE. Ascl1 is required for the generation of GABAergic neurons, most notably in the MGE (Casarosa et al., 1999; Horton et al., 1999) . The reduction in size of the MGE in Ascl1 À/À brains is due to a reduction in proliferation, and lower expression of Dll1 and downstream Notch effectors such as Hes5 (Casarosa et al., 1999) , highlighting the key connection between proneural genes and Notch signaling. Ascl1 is also required to specify an OPC fate in the embryonic ventral telencephalon (Parras et al., 2007) , raising the question of how it selects between GABAergic neuronal and oligodendroglial target genes. To preferentially promote an oligodendrocyte fate, Ascl1 represses the generation of Dlx + progenitors and a GABAergic neuronal fate (Petryniak et al., 2007) . In addition, in the context of high RAS/ERK signaling, which is initiated downstream of several receptor tyrosine kinases (RTKs) and other signaling pathways, Ascl1 promotes a glioblast rather than a neuronal identity (Li et al., 2014) . Ascl1 also has a third function in the ventral telencephalon, which is to promote the proliferation of subpallial progenitors, a function that was uncovered through genome wide profiling of target genes, many of which are positive cell cycle regulators (Castro et al., 2011) . This activity of Ascl1 was unexpected, as proneural genes are classically considered to promote cell cycle exit and neuronal differentiation, but misexpression of Ascl1 can promote proliferation when misexpressed in certain cellular contexts (Castro et al., 2011; Li et al., 2014) . A recent report suggests that Neurog2 may similarly promote proliferation when misexpressed in the neocortex in a limited fashion, at least for the first 16 h postoverexpression (Hagey and Muhr, 2014) .
During embryogenesis, OPCs are generated in the ventral telencephalon and migrate tangentially into the dorsal telencephalon, similar to GABAergic interneurons (Laclef and Metin, 2017) . Both Olig1 and Olig2 are expressed in OPCs in the ventral telencephalon and their expression is sustained during migration (Lu et al., 2000; Tekki-Kessaris et al., 2001; Zhou et al., 2000) . Furthermore, Olig1/2 are required for oligodendrocyte fate specification in the ventral telencephalon (Zhou and Anderson, 2002) .
bHLH gene function in the spinal cord
In the spinal cord, progenitors are distributed in zones based on their position along the dorsoventral axis (reviewed in (Lu et al., 2015) ). Dorsal progenitor zones range from dP1 (closest to the roof plate) to dP6 (more medial), while ventral zones range from p0 (adjacent to dP6) to p3 (closest to the floor plate), with a motor neuron progenitor zone (pMN) located between p2 and p3 ( Fig. 2B ; reviewed in (Ulloa and Briscoe, 2007) ). As progenitors differentiate into interneurons the dorsal domains change from being classified as dorsal progenitor (dP) to dorsal interneuron (dI) domains. The specification of dorsoventral progenitor identity occurs in two steps, beginning with the establishment of fuzzy borders between progenitor domains in response to morphogen gradients; BMPs and Wnts secreted from the dorsal roof plate, and Shh from the ventral floor plate ( Fig. 2B ; (Ulloa and Briscoe, 2007) ). These morphogens act in a concentration-dependent manner to regulate the expression of transcription factors that confer a regional identity. For example, Shh represses Class I target genes (e.g., Pax6, Dbx2) while inducing Class II target genes (eg., Nkx2.2, Nkx6.1) at specific morphogen concentrations. These Class I and Class II genes, which encode homeodomain transcription factors, are cross-repressive, leading to the sharpening of progenitor boundaries.
Many bHLH genes are also expressed in the developing spinal cord, including (Lai et al., 2016) ) and Bhlhe22 (dP6, p1, p2) (Skaggs et al., 2011) . All of these genes are required for the differentiation of different populations of spinal cord neurons and glia. Ascl1 is required for neurogenesis in the spinal cord (Battiste et al., 2007) , with a specific reduction in dI3 and dI5 interneurons observed in Ascl1 À/À spinal cords dorsally (Helms et al., 2005; Mizuguchi et al., 2006) , while v2 interneurons are reduced ventrally (Parras et al., 2002) . Moreover, overexpression of Ascl1 promotes the formation of ectopic dI3 and dI5 interneurons (Muller et al., 2005) . Finally, Ascl1 is required for the generation of spinal OPCs, and their subsequent differentiation into myelinating oligodendrocytes (Sugimori et al., 2007; Sugimori et al., 2008; Vue et al., 2014) . In contrast, Neurog2 functions in the ventral spinal cord, with a reduction in motor neurons and v1-v3 interneurons seen in Neurog2 À/À mice (Parras et al., 2002; Scardigli et al., 2001) . In the embryonic spinal cord, Neurog2 binds retinoic acid receptors (RAR), recruiting them to motor neuron differentiation genes so as to integrate RA motor neuron differentiation signals (Lee et al., 2009; Lee and Pfaff, 2003; Lee et al., 2004) . Olig2 turns on Neurog2 expression in the pMN, and when these two genes are coexpressed, they induce motor neurons to differentiate (Mizuguchi et al., 2001; Zhou et al., 2001) . Conversely, the downregulation of Neurog2 expression and upregulation of Nkx2.2 converts Olig2 to a pro-oligodendrocyte protein (Zhou et al., 2001 ). In contrast, Olig3 is required for the differentiation of dI1-dI3 interneurons, acting through the inhibition of genes that are normally expressed in dI4-dI6 (Muller et al., 2005) . Atoh1 is required for the specification of dI1 dorsal interneurons, and has cross-repressive interactions with Neurog1, which is required for the differentiation of a distinct set of dorsal interneurons (Bermingham et al., 2001; Gowan et al., 2001) . Neurog1 is further involved in the ventral spinal cord, where, along with Neurog2, it is required for the differentiation of the full complement of motor neurons and ventral interneurons (Scardigli et al., 2001) . Finally, Bhlhe22 is required for the differentiation of v1 interneurons (Skaggs et al., 2011) .
bHLH gene function in the hindbrain
The dorsal hindbrain, which surrounds the fourth ventricle and is also known as the rhombic lip, gives rise to neurons that populate hindbrain nuclei (e.g., cochlear nucleus, pre-cerebellar and deep-cerebellar nuclei, etc.). The hindbrain forms on the caudal side of the isthmus, also known as the mid-hindbrain boundary (MHB), with Fgfs acting as the main inductive pathway (reviewed in (Butts et al., 2014a) ).
At maturity, the cerebellum has a very precise folding pattern, and is divided into 10 lobules and 4 transverse domains. It is comprised of two main cell types; Purkinje cells, which form a monolayer in the center, and mature granule cells, which are found in an underlying internal granular layer (IGL). During development, an external granular layer (EGL) containing granule cell precursors overlies the Purkinje cell layer.
In the embryonic and early postnatal period, granule cell precursors in the outer EGL express Atoh1, and proliferate in response to Shh, which is secreted by Purkinje cells (Ben-Arie et al., 1997) . The EGL persists until P21, and during this time, Atoh1 is required for the proliferation and amplification of granule cell precursors (Flora et al., 2009) , and it prevents these cells from differentiating (Klisch et al., 2011) . In order for granule cell precursors to differentiate, they must downregulate Atoh1 expression and begin to express Neurod1, which inhibits transit amplification, at least in amphibians (Butts et al., 2014b) .
Ascl1 is also expressed in VZ progenitors in the hindbrain, where it is required for the differentiation of cerebellar interneurons (Sudarov et al., 2011) . Neurog2 + progenitors also give rise to Purkinje cells, and in the absence of Neurog2, there is an overall reduction in cerebellar size, and Purkinje cells have poorly developed dendritic arbors (Florio et al., 2012) . There are also other hindbrain nuclei, and Atoh1 is involved in their generation, including the respiratory rhythm generators, such that Atoh1 À/À mice die perinatally from severe apnea (Rose et al., 2009 ). In addition, Nhlh1 and Nhlh2 are together required for the migration of neurons that form pre-cerebellar nuclei in the pons and medulla oblongota (Schmid et al., 2007) . Finally, Ascl1 is required for the differentiation of a subset of serotonergic neurons in the hindbrain (Pattyn et al., 2004) .
bHLH gene function in the retina
The optic vesicles first arise from an evagination of the diencephalon at E8.5 in mouse (Wawersik and Maas, 2000) . The optic vesicles then invaginate at E10 to form a bilayered optic cup that is the anlage of the neural retina and retinal pigment epithelium (RPE) (Fig. 2C) . The first neurons to differentiate are the retinal ganglion cells (RGCs), which first appear at $E11.5, followed closely by cone photoreceptors, and horizontal and amacrine cell interneurons, which are generated in an overlapping fashion during the embryonic period (Young, 1985) . The remaining retinal cell types, including rod photoreceptors, bipolar cells and Müller glia, begin to differentiate in late embryogenesis, with their genesis peaking in the early postnatal period, and ending by postnatal day (P) 12.
Several bHLH genes are expressed in the embryonic retina, including the proneural genes Neurog2, Ascl1, Neurod4, and Atoh7, and the differentiation genes Neurod1, Neurod2, Neurod6, Bhlhbe22 and Olig2 (Cherry et al., 2011) . In general, developmental defects in the retina are rather subtle when individual bHLH genes are knocked out. One exception is the proneural gene Atoh7, which is required for the generation of most RGCs in mouse (Brown et al., 2001; Wang et al., 2001 ) and zebrafish (Kay et al., 2001) . The timing of RGC neurogenesis is also controlled by Neurog2, with a delay in early RGC genesis observed in Neurog2 À/À retinas (Hufnagel et al., 2010) . The ectopic expression of Ascl1, which appears at E12.5 in the Neurog2 À/À retina, as opposed to its normal onset after E14.5, has been suggested to rescue early RGC differentiation defects (Hufnagel et al., 2010) . However, Ascl1 is not required for the differentiation of RGCs (Tomita et al., 1996) , and lineage tracing suggests that Ascl1 + progenitors do not give rise to RGCs (Brzezinski et al., 2011) , consistent with the lack of Ascl1 expression until after E14.5 (Dixit et al., 2014a) , when RGC genesis is almost complete. Ascl1 is also not required for the genesis of other early-born retinal cell types, although there is a reduction in normally late-born bipolar cells in Ascl1 À/À retinal explants grown to the equivalent of postnatal stages (Tomita et al., 1996) . In Xenopus retina, Ascl1 is required and sufficient to promote the differentiation of GABAergic neurons (Mazurier et al., 2014) , but this function does not appear to be conserved in the murine retina, possibly because of compensatory effects from other bHLH genes. Of the retinal differentiation bHLH genes, the loss of Neurod1 results in the degeneration of photoreceptors (Cho et al., 2007; Ochocinska et al., 2012) , while there is a reduction in AII amacrine cells in Neurod2 mutants (Cherry et al., 2011) . Bhlhbe22 is required for the differentiation of GABAergic amacrine cells and cone bipolar cells (Feng et al., 2006; Huang et al., 2014) . Finally, while Olig2 function has not been assessed, based on lineage tracing, Olig2 + retinal progenitor cells are biased towards terminal divisions and preferentially gave rise to rods and amacrine cells (Hafler et al., 2012) .
More severe defects in retinal development are only observed in triple bHLH gene mutants (Akagi et al., 2004) , highlighting the ability of these genes to compensate for one another. In Ascl1
À/À retinas, fewer amacrine, horizontal and bipolar cells are generated, while more Müller glia and RGCs differentiate (Akagi et al., 2004) . In Neurog2
there are only two cell layers, with the outer layer containing photoreceptors, a few amacrine cells and an expanded pool of Müller glia, whereas there are virtually no bipolar or horizontal cells. In the second layer there are a reduced number of RGCs (Akagi et al., 2004) . Finally, in Ascl1
there are fewer photoreceptors and bipolar cells, whereas RGCs and Müller glia are increased in number (Akagi et al., 2004) . The increase in Müller glia, which are the last born cell type, in all three triple mutants, suggests that the proneural genes are required to regulate the timing of the switch from neurogenesis to gliogenesis (Akagi et al., 2004) . Another important finding is that in the absence of the different bHLH genes, other bHLH genes are upregulated (e.g. Ascl1, Neurog2 and Neurod4 are upregulated in Neurod1 mutant retinas) (Cho et al., 2007) , similar to the upregulation in Ascl1 expression in Neurog2 mutants in the neocortex (Fode et al., 2000) . There are thus multiple cross regulatory interactions between bHLH transcription factors that appear to be compensatory.
Conclusions and Future directions
When comparing the functions of bHLH transcription factors across the different subdivisions of the neural tube, one of the most striking features is that individual factors can specify distinct cell fates in different domains. A major question is how the same transcription factor can have such diverse roles. One reason is that these bHLH transcription factors are tightly regulated through a host of different post-transcriptional and post-translational events, as highlighted further below. Another interesting feature of these genes is the extent of their regulatory interactions. Most notably, Neurog2 is required to repress the expression of Ascl1 in both the retina and forebrain, and other regulatory interactions between bHLH factors have been uncovered in the retina and other regions of the neural tube. These repressive functions of the proneural genes were not expected, as they were considered to be transcriptional activators. Indeed, the ability of Neurog2 to repress a set of genes is an indirect process, involving the transactivation of downstream repressors (Kovach et al., 2013) . Unravelling the regulatory interactions between bHLH genes, and the extent to which they are redundant or have distinct functions, still remains a challenge.
Regulation of bHLH transcription factors
5.1. Regulation of bHLH transcription factor expression by signaling pathways 5.1.1. Notch signaling bHLH transcription factors, especially those with proneural function, have a known association with the Notch signaling pathway (Fig. 3A) . Proneural bHLH transcription factors transactivate Notch ligands (eg., Delta1 (Dll1)/Dll3), which then bind Notch receptors on neighboring cells to repress proneural expression through a process known as lateral inhibition (Castro et al., 2006) . Upon Dll1/3 ligand binding, the Notch receptor is cleaved, resulting in nuclear translocation of the Notch intracellular domain (NICD), which interacts with Rbpj (CSL) to activate the transcription of Hes genes (Honjo, 1996; Ohtsuka et al., 1999; Selkoe and Kopan, 2003) . Hes transcription factors recruit Groucho/TLE corepressor complexes to N-boxes (CACNAG) in promoter and enhancer elements to repress gene transcription (Bai et al., 2007; Kageyama et al., 2008; Ohsako et al., 1994; Ross et al., 2003) . When Hes transcription factors become highly expressed, proneural genes are repressed (Bertrand et al., 2002; Chen et al., 1997; Ross et al., 2003) . Hes transcription factors can further interfere with proneural transcription factors by binding and sequestering Eproteins that would normally dimerize with them (Alifragis et al., 1997; Bertrand et al., 2002; Kageyama et al., 2008; Ross et al., 2003) .
While proneural activity in one cell may lead to proneural repression in neighboring cells, this repressive state is not stable. Hes proteins are autoregulatory, meaning that they are able to repress their own promoters, and can initiate oscillatory promoter activity (Shimojo et al., 2008; Takebayashi et al., 1994) . Within a given cell, Hes oscillations create a state whereby proneural genes and Hes genes oscillate inversely with each other in two to three hour cycles (Imayoshi et al., 2013; Shimojo et al., 2008) . Proneural genes thus create intercellular inhibition while Hes genes create intracellular oscillations. Similar oscillations have been observed with Ascl1, also under the repressive control of Hes1 (Chen et al., 1997; Imayoshi et al., 2013) . However, this mechanism is not common to all bHLH transcription factors, as Olig2 has a distinct oscillatory pattern that is independent of Hes1 (Imayoshi et al., 2013) . Finally, NeuroD regulates Notch activity in the developing retina, but whether it acts in an oscillatory manner is unknown (Taylor et al., 2015) .
Wnt signaling
Wnt signaling is an important regulator of bHLH gene transcription (Fig. 3B) . Wnt signaling is able to induce expression of Neurog2 and is a direct regulator of Atoh1 (Gunhaga et al., 2003; Machon et al., 2005; Shi et al., 2010; Watanabe et al., 2005) . Wnt signaling is also likely a direct regulator of Neurog1, as Lef binding sites reside within the Neurog1 regulatory region (Hirabayashi et al., 2009 ). Indeed, Wnt signaling components are sufficient to induce ectopic expression of both Neurog1 and Neurog2 in the ventral telencephalon (Gunhaga et al., 2003; Israsena et al., 2004; Machon et al., 2005; Watanabe et al., 2005) . In the case of Neurog2, regulation by Wnt signaling is temporally restricted, as disruption of Wnt signaling reduces Neurog2 expression during early but not late cortical neurogenesis (Bluske et al., 2012; Machon et al., 2005) . Wnt is also able to increase Ascl1 expression in cultured cells, and regulates NeuroD1 expression in the hypothalamus and adult hippocampus (Kuwabara et al., 2009; Lee et al., 2016; Tang et al., 2002) .
BMP signaling
A similar temporally-dependent regulation of Neurog2 is observed with Bmp signaling (Fig. 3C) , as Bmp7, which is secreted from the hem, meninges and choroid plexus, is required after E14.5 to maintain Neurog2 expression in SVZ progenitors in the cortex (Segklia et al., 2012) . BMP signaling also limits oligodendrogenesis through an indirect action on Olig1/2 proteins (Samanta and Kessler, 2004) . In the cerebellum, BMP signaling can prevent Shh-induction of proliferation of granule cell precursors by downregulating Atoh1 expression through proteasome-mediated degradation (Zhao et al., 2008) . Interestingly, BMP2 also induces the degradation of Ascl1 protein (Vinals et al., 2004) .
Fgf signaling
When dissociated cortical cells are exposed to Fgf or downstream effectors in this pathway (eg., RAS/ERK signaling) in vitro or in vivo, there is a switch from Neurog2 to Ascl1 expression (Fig. 3D) . This signaling pathway thus controls the selection of cell fate by deciding which proneural gene is expressed, with Neurog2 promoting the differentiation of glutamatergic neurons in the cortex, while ectopic Ascl1 specifies a GABAergic neuronal or OPC fate (Li et al., 2014) .
Regulation of bHLH transcription factor function by phosphorylation
The proneural activity of bHLH proteins is also regulated by phosphorylation ( Fig. 4 ; reviewed in (Guillemot and Hassan, 2017) ). Neurog2 harbours multiple conserved SP and TP sites that are phosphorylated by proline-directed serine-threonine kinases, such as Cdk1, GSK3 and ERK. In Xenopus, phosphorylation of Neurog2 by Cdk1 has an additive effect, with DNA binding reduced with each additional phosphorylation event, functioning as a rheostat-like control mechanism to limit neurogenesis (Ali et al., 2011) . Cdk1 also phosphorylates Ascl1 (Ali et al., 2014) and Neurod4 (Hardwick and Philpott, 2015) in Xenopus, both of which have six SP/TP sites, reducing the ability of these proneural proteins to promote primary neurogenesis.
A similar mode of regulation by proline-directed serinethreonine kinases has been observed in the murine neocortex, where low Wnt signaling at late stages (>E14.5) leads to elevated GSK3 activity and an increase in Neurog2 phosphorylation on SP sites (Li et al., 2012) . Similarly, Ascl1 is phosphorylated by ERK, another proline-directed serine-threonine kinase (Li et al., 2014) . Interestingly, when Neurog2 becomes phosphorylated, it changes its choice of dimerization partners, preferentially forming Neurog2-E47 heterodimers rather than Neurog2-Neurog2 homodimers, and these Neurog2-E47 heterodimers have a reduced ability to induce neuronal differentiation (Li et al., 2012) . Neurog2 is also phosphorylated by GSK3 in the murine spinal cord, but here it promotes the association of Neurog2 with Nli1, an adaptor protein that recruits Lhx3 and Isl1 to target genes to induce motor neuron differentiation . Phosphorylation of proneural proteins by proline-directed serine threonine kinases may thus be a conserved mechanism, not only reducing proneural activity at different stages of development, but also directing neuronal subtype specification.
Interestingly, the inhibitory effects of SP/TP phosphorylation of Neurog2 are observed on neuronal differentiation genes, such as xNeurod1, but not on xDelta (Hindley et al., 2012) . Similarly, at low levels of ERK activation, presumably correlating with reduced Ascl1 phosphorylation, Ascl1 can activate neuronal differentiation genes, whereas at higher levels of ERK activation, Ascl1 preferentially transactivates glial genes (Li et al., 2014) . Ascl1 is directly phosphorylated by ERK, with serine to alanine mutations of the six putative ERK phosphoacceptor sites (SP sites) sites in Ascl1 enhancing the ability of Ascl1-SA6 to induce neurogenesis, and reducing its ability to promote gliogenesis (Li et al., 2014) . In this context, Ascl1 phosphorylation is used to select downstream targets.
During spinal cord development, phosphorylation of Olig2 determines whether motor neurons or OPCs are specified, with the phosphorylated form of Olig2 specifying a motor neuron fate (Li et al., 2011) . Olig2 phosphorylation changes Olig2 dimerization from Olig2-Neurog2 heterodimers (unphosphorylated) to Olig2-Olig2 homodimers (phosphorylated) (Li et al., 2011) . The formation of unphosphorylated Olig2-Neurog2 heterodimers prevents Neurog2 from binding downstream targets required for motor neuron specification, thus leading instead to the selection of oligodendrocyte target genes and an oligodendrocyte fate.
Additional residues are phosphorylated in bHLH proteins, including a conserved S/T phosphoacceptor site in the second helix that is found in Neurog, Ascl and Atonal homologs from fly to humans (Quan et al., 2016) . Phosphorylation of this site inactivates proneural activity to control the activities of these proteins in a precise temporal-spatial fashion (Quan et al., 2016) . Neurog2 is also phosphorylated on Y241, leading to the transactivation of downstream targets associated with neuronal migration (Hand et al., 2005) . For Atoh1, phosphorylation at S193 is required for proper maintenance of mechanosensory hair cells in the inner ear (Xie et al., 2017) .
Epigenetic regulation of bHLH transcription factors

Ascl1
Transcription factor binding to nucleosomal DNA is considered to be pioneer activity (Fig. 5A) . In the ventral telencephalon, over half of the sites that Ascl1 binds to in the enhancer regions of its target genes are found in closed chromatin (Raposo et al., 2015) . More strikingly, upon binding, Ascl1 opens the chromatin so that other transcription factors can also bind, leading to its designation as a pioneer factor (Raposo et al., 2015) . This pioneer activity of Ascl1 has also been observed during neuronal reprogramming of fibroblasts (Wapinski et al., 2013) . Similarly, in glioblastoma cell lines, Ascl1 binds to nucleosome rich, closed chromatin, inducing a reorganization or opening that allows Ascl1 to promote neurogenesis (Park et al., 2017) . How Ascl1 induces chromatin opening remains to be deciphered.
Neurog1
Neurog1 expression is repressed by Polycomb group (PcG) proteins at later stages of development to allow gliogenesis to initiate (Fig. 5B) (Hirabayashi et al., 2009 ). It has also been found that a 4 kb enhancer region that controls Neurog1 expression generates a non-coding RNA (utNeurog1) that is required for efficient Neurog1 transcription (Fig. 5C) (Onoguchi et al., 2012) . The tight regulation of Neurog1 expression in the neocortex is thus regulated at the epigenetic level.
Neurog2
A major question is how proneural genes can activate their downstream targets in somatic cells in which the chromatin surrounding neuronal differentiation genes is closed. Neurog2 accomplishes this feat in part by binding to histone acetyltransferases, such as CBP/p300 (Lee et al., 2009) . In Xenopus, Neurog2 interacts with an H3K9 demethylase known as KDM3A during the formation of primary neurons (Lin et al., 2017) . This interaction facilitates Neurog2 binding to the regulatory regions of neuronal differentiation genes (Neurod1, Tubb3) by removing repressive H3K9me2 marks, and facilitating the addition of open chromatin marks H3K27ac and H3K4me3 (Lin et al., 2017) . Xenopus Neurog2 has also been shown to interact with Brg1, a chromatin remodelling protein, as does Neurod1, and these interactions are essential for neuronal differentiation (Seo et al., 2005) .
Conclusions and future directions
From these studies, it is evident that the regulation of bHLH gene expression and function is very tightly regulated. Furthermore, it is clear that we have only scratched the surface in this area, given for example, that it remains unclear how Ascl1 opens chromatin. The strict controls on bHLH expression highlights the importance of these genes in regulating cell fate decisions, and the very tight regional and temporal controls that are required to ensure that bHLH transcription factors are only active in the correct time and place. Future studies should be directed to examining whether some of the regulatory mechanisms described in this review apply to a larger number of bHLH factors, or whether they are unique attributes of the genes described. For example, it would be surprising if only Neurog1 was subject to PcG-mediated repression, given the high relatedness to Neurog2. However, one could also argue that Neurog1 is expressed in a much shorter time window in the neocortex, so PcG-repression may allow for the distinct expression patterns of these two genes.
6. bHLH transcription factors in health and disease 6.1. bHLH genes in cancer 6.1.1. Glioma
While the direct mutation of bHLH genes is not the underlying cause of most cancers, their dysregulation has been observed in various tumors. Gliomas are brain tumors that originate in glial cells, and they include both astrocytomas (e.g., glioblastoma multiforme, or GBM), which are the most aggressive gliomas, and oligodendrogliomas (ODG) (Fig. 6A) . Gliomas represent approximately 80% of all malignant brain tumors, and are thus a major focus of health research. Strikingly, ASCL1 is expressed in many gliomas, at low and high levels depending on tumor type (Phillips et al., 2006; Rheinbay et al., 2013; Rousseau et al., 2006; Somasundaram et al., 2005) , and it is required for the proliferation and maintenance of these cells in an animal model of GBM (Rheinbay et al., 2013) . ASCL1 influences tumor growth through regulation of the Wnt pathway, as knockdown of ASCL1 leads to decreased Wnt signaling (Rheinbay et al., 2013) . There is also evidence that higher levels of ASCL1 expression may make tumors more responsive to Notch inhibition, which allows for the latent proneural activity of ASCL1 to be activated, leading to cell cycle exit and neuronal differentiation (Park et al., 2017) . In contrast, glial tumors that express low levels of ASCL1 are not responsive to Notch inhibitors, suggesting that ASCL1 status should be considered as a prognostic of drug responsiveness. Finally, a more recent study has found that GBMs expressing a higher level of ASCL1 have the potential to undergo neuronal differentiation and stop tumor spread in response to the inhibition of Notch signaling (Park et al., 2017) . To induce neurogenesis, ASCL1 acts as a pioneer factor, binding to DNA and opening chromatin around its differentiation targets (Park et al., 2017) .
ASCL1 is also expressed in pilocytic astrocytomas and gangliogliomas, which are less aggressive tumors. While these tumors share the same bRAFV600E mutation, the higher level of ERK activation in pilocytic astrocytomas results in more glial and less abnormal neuronal cells in the tumor (Li et al., 2014) . This increase in abnormal gliogenesis is thought to be due in part to the hyperphosphorylation of ASCL1 by ERK, which promotes a glial fate (Li et al., 2014) .
Astrocytomas are also characterized by the expression of OLIG2 (Fig. 6B) (Bouvier et al., 2003; Ligon et al., 2004; Ligon et al., 2007; Lu et al., 2001b; Marie et al., 2001; Ohnishi et al., 2003) , which is required for tumorigenicity (Ligon et al., 2007; Mehta et al., 2011; Suva et al., 2014) . In mouse models of glioma, the loss of Olig2 allows for enhanced survivability and a lack of symptoms (Ligon et al., 2007; Mehta et al., 2011; Suva et al., 2014) . The phosphorylation state of Olig2 is also important as a phosophomimetic In addition, an utNeurog1 non coding transcript is generated from the enhancer region upstream of Neurog1, which is required to facilitate the transcription of Neurog1.
form of Olig2 increases tumorigenicity in a glioma model (Sun et al., 2011) . The role of OLIG2 in tumorigenicity appears to be due, at least in part, to the OLIG2 protein suppressing acetylation of p53 in glioma cells (Mehta et al., 2011) . While OLIG2 expression may not directly induce astrocytomas, targeting OLIG2 activity may represent a potential therapeutic strategy for managing tumor growth.
Neuroblastoma
Neuroblastoma is considered to be a developmental tumor arising from undifferentiated progenitors that normally give rise to the sympathetic nervous system ( Fig. 6C ; reviewed in (Maris et al., 2007) ). The presentation of neuroblastoma is highly variable and can occur anywhere in the sympathetic nervous system. A recent report showed that ASCL1 is hyper-phosphorylated on SP sites in neuroblastoma cell lines, and that phosphorylated ASCL1 prevents the differentiation of anteroventral noraderenergic cells (AVNA), which are thought to be the cells that give rise to neuroblastoma (Wylie et al., 2015) . A defect in differentiation may thus be the underlying cause of neuroblastoma, and the phosphorylation status of ASCL1 may contribute to this defect (Wylie et al., 2015) .
Medulloblastoma
Medulloblastoma is the most common brain tumor found in children, and is a malignant tumor of the cerebellum (Fig. 6D) . In a subset of medulloblastomas, ATOH1 is upregulated (Salsano et al., 2004) , and tumor formation is prevented in mouse models in which Atoh1 is deleted (Flora et al., 2009) . These data have suggested that the upregulation of genes associated with a granule cell precursor identity are associated with a poor prognosis (Schuller et al., 2008; Yang et al., 2008) . The role of ATOH1 in controlling medulloblastoma proliferation appears to occur through regulation of the Shh signaling pathway (Flora et al., 2009 ). NHLH1 has also been shown to be a target of Shh signaling in the developing cerebellum and in medulloblastoma (De Smaele et al., 2008) .
bHLH genes in neurodevelopmental, neuropsychiatric and neurodegenerative disorders 6.2.1. Eye disorders
The most notable pathologies linked to mutations in bHLH genes are found in the eye, mostly affecting ATOH7, which is required for RGC differentiation and early eye development in animal models (Huang et al., 2014) . Patients with ATOH7 mutations develop persistent hyperplasia of the primary vitreous and have bilateral optic nerve aplasia (Prasov et al., 2012) . Moreover, in a genetic screen of consanguineous Pakistani families with Nonsyndromic Congenital Retinal Non-Attachment (NCRNA), a form of blindness caused by separation of the retina and posterior globe, three families contained mutations in a conserved region of ATOH7 (Keser et al., 2017) . A separate study found a 6.5 kb deletion in an enhancer element for ATOH7 in a Kurdish population with NCRNA (Ghiasvand et al., 2011) . Finally, a weaker link has been made between ATOH7 and primary open angle glaucoma, a glaucoma subtype associated with an imbalance in the production and drainage of aqueous humor in the anterior chamber (Axenovich et al., 2011; Ramdas et al., 2011) . Similarly, ATOH7 is one of 8 genes with possible pathogenicity associated with microphthalmia, anophthalmia and coloboma (MAC) (Williamson and FitzPatrick, 2014) . The severity of human ocular defects associated with ATOH7 mutations are more severe than observed in mutant mice, but are consistent with an early role for Atoh7 in retinal development (Huang , 2014) . Finally, visual impairments have also been detected in a patient who was homozygous for a null mutation in NEUROD1, which led to several visual defects, including nyctalopia, blurred vision, and constriction of the visual field (Orosz et al., 2015) . These defects are consistent with the known role of Neurod1 in photoreceptor survival in animal models (Cho et al., 2007; Ochocinska et al., 2012) .
Neuropsychiatric disorders
The link between bHLH transcription factors and neuropsychiatric disorders is fairly weak, yet there are some connections. A polymorphism within the NEUROG1 regulatory region has been linked to language deficits (Ho et al., 2008) . A region linked to schizophrenia, Chr 5q31, contains the NEUROG1 locus in humans. Within schizophrenia patients, those with a NEUROG1 polymorphism have decreased verbal memory, language skills, and visuospatial abilities (Ho et al., 2008) . Schizophrenia patients with a polymorphism in the NEUROG1 regulatory region have decreased cerebral gray matter volume (Ho et al., 2008) . While NEUROG1 polymorphisms do not appear to have a causative role in schizophrenia, these polymorphisms do indicate more severe outcomes. The deficits observed in schizophrenia patients with NEU-ROG1 polymorphisms likely highlight important developmental functions for NEUROG1 in the developing human cortex.
Mutations in NEUROD2 have been associated with schizophrenia and schizoaffective disorder (Spellmann et al., 2017) . NEUROD2 polymorphisms in schizophrenia patients were associated with diminished verbal memory and executive functions (Spellmann et al., 2017) .
Neurodegenerative disorders
Given the variety of developmental functions of bHLH genes, some associations with neurodevelopmental disorders or diseases with aberrant cell cycling were expected. However, neurodegenerative disorders with an adult onset seemed less likely to be linked to bHLH mutations. Indeed, only one gene, ASCL1, has been implicated in a neurodegenerative disorder, with polymorphisms in this gene associated with Parkinson's disease, a neurodegenerative disorder that affects dopaminergic neurons in the nervous system (Ide et al., 2005) . The role of ASCL1 in Parkinson's disease appears to be mediated through interactions with PHOX2b. ASCL1 may be involved in Parkinson's disease through proper developmental control of the locus coeruleus, a region believed to provide protection against the neurodegenerative effect of Parkinson's disease (Ide et al., 2005) . NEUROG2 has been investigated for a potential association with Parkinson's disease, but the results indicated that it is unlikely to be involved (Deng et al., 2010) . Finally, NEUROD6 is downregulated in Alzheimer's Disease, which is a common cause of dementia, and has been suggested to be a potential biomarker (Satoh et al., 2014) .
Conclusions and future directions
Collectively, these studies indicate that mutations in bHLH genes are not a major feature of hereditary disease, probably because most of these genes are essential to embryonic development, neural cell differentiation and survival. Indeed, neuropsychiatric and neurodegenerative disorders have very little association with bHLH genes. The greatest exception is ATOH7, mutations of which are linked to visual impairments in more than one population. However, a better link needs to be established between ATOH7 mutations and visual development outside of the consanguineous populations currently studied.
Furthermore, somatic mutations in bHLH genes are not commonly found in tumors, although the de-regulated expression of many of these genes is observed in many cancers. Targeting bHLH genes may thus still be meaningful in tumor treatment. For instance, given the progenitor-like behaviour of tumor cells, dysregulation of bHLH factors may also disrupt proliferation within the tumor, as has been shown for Olig2 in mouse models (Ligon et al., 2007; Mehta et al., 2011; Suva et al., 2014) . Indeed, the overexpression of Neurog2 or Neurod1 in GBM stem cells promotes cell death, with remaining live cells acquiring neuronal features (Guichet et al., 2013) . Another study similarly found that the overexpression of Ascl1, Brn2 and Neurog2 can induce human glioma cells to undergo neuronal differentiation and stop proliferating (Zhao et al., 2012) , while another study reported that the expression of Sox11 and Neurog2 together in human glioma cells in vivo blocks tumor growth (Su et al., 2014) . The possibility that bHLH transcription factors may be exploited for the treatment of brain tumors is thus a real possibility.
bHLH transcription factors in reprogramming
A general overview of neuronal reprogramming
Developmental biologists have paved the way for the field of direct neural cell reprogramming by identifying both intrinsic and extrinsic cues that induce neurogenesis and gliogenesis and specify neural subtype identities (Masserdotti et al., 2016) . The use of developmental genes in reprogramming strategies has led to the successful generation of a large variety of neural cell types resembling cells in the CNS and PNS. The further refinement of neural cell reprogramming strategies brings hope for the treatment of neurodegenerative disorders and for the repair of damage caused by stroke or other insults. In developing techniques for reprogramming cells, there has been a major focus on the use of bHLH genes, especially proneural transcription factors (Fig. 7) .
Fibroblasts and other somatic cells
Stepwise lineage conversion strategies have been devised for the reprogramming of somatic cells, such as fibroblasts, to an induced neuronal (iN) identity. bHLH transcription factors have emerged as critical architects of neuronal reprogramming. They were first shown to induce neuronal differentiation in P19 cells, with Ascl1, Atoh1, Neurod1, Neurod2, Neurod4, Neurod6, Neurog1, Neurog2, or Nhlh1 inducing neurogenesis in this embryonal carcinoma cell line (Farah et al., 2000) . The first report of direct neuronal reprogramming in fibroblasts used three factors; Ascl1, Brn2 and Mytl1 (BAM) (Vierbuchen et al., 2010) . Since then the field has exploded and multiple approaches have been devised. Ascl1 has emerged as a potent reprogramming factor in vitro, acting in combination with other transcription factors to convert mouse and human fibroblasts (Caiazzo et al., 2011; Kim et al., 2011; Pang et al., 2011; Pfisterer et al., 2011; Son et al., 2011; Vierbuchen et al., 2010) , hepatocytes (Marro et al., 2011) , cardiomyocytes (Chuang et al., 2017) or astrocytes (Rivetti di Val Cervo et al., 2017) to neurons. While proneural genes can induce neuronal reprogramming, neuronal subtype identity is determined by the combination with other factors. For example, transfection of fibroblasts with Ascl1 alone is sufficient to generate iNs (Chanda et al., 2014) , but when Ascl1 is cotransfected with Pitx3, the resulting iNs are dopaminergic (Kim et al., 2011) , whereas when Ascl1 is overexpressed with Neurog1, Brn2, Myt1l, Isl1, and Klf7, the result is nociceptor-like sensory neurons (Wainger et al., 2015) . Notably, Ascl1 is replaceable in sensory neuron programming, as Neurog1 or Neurog2 along with Brn3a can also induce nociceptor as well as mechanoreceptor and proprioceptor sensory neurons (Blanchard et al., 2015) . Proneural factors thus appear functionally redundant in inducing fibroblasts into sensory neurons.
Much like Ascl1, Neurog2's ability to reprogram fibroblasts appears dependent on other factors. When cotransfected with Sox11, Lhx3, and Isl1, Neurog2 is able to convert fibroblasts into motor neurons (Liu et al., 2016) . When forskolin and dorsomorphin are added, Neurog2 instead converts fibroblasts into cholinergic neurons (Liu et al., 2013) . For retinal cell reprogramming strategies, overexpression of the bHLH transcription factor NeuroD1 with Crx, Rax, and Otx2, induces fibroblasts to form photoreceptors (Seko et al., 2014) . These induced photoreceptors appear functional as they exhibit electrophysiological responses to light stimuli.
Notably, neural lineage conversion of fibroblasts with bHLH transcription factors has not been limited to neurons. OPCs have also been successfully generated from fibroblasts using Olig2 and Sox10 with either Zfp536 or Nkx6.2 (Najm et al., 2013; Yang et al., 2013) . The ability to induce OPCs is of considerable importance in finding ways to treat demyelinating diseases such as optic neuritis and multiple sclerosis.
Pluripotent stem cells -Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs)
The generation of iNs from pluripotent stem cells, whether it be from embryonic stem (ES) or induced pluripotent stem (iPS) cells, is considered a differentiation process, rather than a lineage conversion event. Neural induction is initiated in pluripotent cells in a stepwise manner by first inhibiting BMP and Activin/TGFb signaling to generate induced NSCs, and then initiating neuronal differentiation by the addition of various small molecules and signaling molecules (Chambers et al., 2009 (Wang and Zhang, 2017) ). However, such procedures are generally timeconsuming and relatively inefficient. The induction of neuronal differentiation can be greatly improved by the overexpression of transcription factors, notably including several bHLH genes. For instance, Neurog1 and Neurog2 have been overexpressed in human iPS cells to induce neuronal differentiation (Busskamp et al., 2014) . By combining Neurog2 with Islet1 and Lhx3, human ES cells can be converted into motor neurons (Hester et al., 2011) . Finally, Neurog2 alone is also sufficient to convert human ES or iPS cells into neurons (Zhang et al., 2013) . The efficiency of neuronal differentiation from a source of human pluripotent cells has also been dramatically improved by the use of synthetic mRNAs for the bHLH factors Neurog1, Neurog2, Neurog3, Neurod1 and Neurod2, as opposed to the plasmid-based or viral expression constructs used by others (Goparaju et al., 2017) . Such an approach has the advantage of not altering the genome, as occurs with viral expression constructs, and mRNAs can be quickly translated into protein product.
Aside from the more commonly used bHLH transcription factors, Atoh1 has been used along with Gfi1 and Pou4f3 to reprogram mouse ES cells into hair cells of the inner ear (Costa et al., 2015) . Neurog1 transfection of mesenchymal stem cells was also able to induce some aspects of a cochlear neuron identity (Schack et al., 2016) . The inability of Neurog1 to fully specify cochlear neurons may be a limitation of Neurog1 in inducing cochlear neurons or a limitation of using mesenchymal stem cells for reprogramming to a neuronal fate.
Glia and other neural cells in the brain
While some promising work has been done using fibroblast reprogramming, many labs have turned their focus to in vivo strategies for repairing the brain, namely the reprogramming of astrocytes into neurons. Several bHLH transcription factors have Fig. 7 . Neural cell reprogramming using bHLH transcription factors. Three main sources of cells are used for reprogramming or directed differentiation; pluripotent cells (ES and iPS), astrocytes (usually in vivo) and fibroblasts. Multiple bHLH genes are efficient at neuronal induction, including Neurog2, Ascl1, Neurod1 and Neurod4. These genes can produce multiple different types of neurons -schematized here are glutamatergic and GABAergic. Olig2 can also be used in combination with other factors to generate oligodendrocytes. been used to successfully convert astrocytes into neurons. Neurog2, Ascl1, and NeuroD1 are each sufficient to convert astrocytes into neurons (Berninger et al., 2007; Brulet et al., 2017; Guo et al., 2014) . In wound injury models, the expression of Olig2 inhibits the transformation of glial cells into neurons, as Olig2 knockdown, using miR-Olig2, is enough to reprogram glial cells into neurons (Buffo et al., 2005) . Much like its developmental role, Ascl1 is promiscuous in reprogramming specific subtypes of neurons. When transfected into astrocytes of the dorsal midbrain, Ascl1 converts astrocytes into neurons with glutamatergic and GABAergic identities (Liu et al., 2015) . In contrast, Ascl1 does not induce neurogenesis when misexpressed in the adult neocortex (Grande et al., 2013) , and in the hippocampus and spinal cord, instead promoting oligodendrogliogenesis (Jessberger et al., 2008; Ohori et al., 2006) .
Perhaps the most successful bHLH factor for reprogramming astrocytes is NeuroD4. Expression of NeuroD4 was sufficient to reprogram both mouse and human astrocytes into neuronal fates (Masserdotti et al., 2015) . While Neurog2 can regulate NeuroD4 expression, the ability to bind the NeuroD4 promoter is limited by REST repression (Masserdotti et al., 2015) . The restrictions imposed by REST are circumvented by reprogramming using NeuroD4 instead of Neurog2 in astrocytes.
In using astrocytes an important consideration in reprogramming strategies is whether the location of the astrocytes within the CNS restricts the neuronal subtypes that may be generated from them. Previous attempts to reprogram astrocytes have had variable outcomes that appeared to be in accordance with the source of astrocytes (Liu et al., 2015; Masserdotti et al., 2015) . However, it is difficult to compare outcomes when there is variability in the techniques used. Chouchane et al. (2017) have nicely shown how regional identity influences reprogramming using astrocytes transfected with Neurog2. Astrocytes from both the neocortex and the cerebellum were isolated and transfected with Neurog2. Neurog2 transfected astrocytes were subsequently transplanted back into the neocortex, with only the cortically isolated astrocytes successfully generating glutamatergic neurons (Chouchane et al., 2017) . The source of astrocytes thus influences the ability of a transfected agent to reprogram specific neuronal subtypes.
Müller glia in the retina
While regeneration occurs not at all, or in a very limited manner, in warm-blooded vertebrates, it is a very efficient process in cold-blooded vertebrates, such as fish and frogs (reviewed in (Gemberling et al., 2013) ). One of the best studied regenerative systems is the neural retina, where retinal cell types are replaced in a very specific fashion in fish and frogs (i.e., if photoreceptors die, then they are the cells that are replaced) (reviewed in (Gemberling et al., 2013) ). The origin of new cells in a degenerative model are the Müller glia, which de-differentiate and proliferate to become retinal progenitor cells that can then re-differentiate into lost cell types, whatever they might be ( Fig. 8 ; reviewed in (Gemberling et al., 2013) ). One of the key factors that determines whether a proliferative Müller glial cell will undergo regeneration is the proneural gene ascl1a (Fausett et al., 2008) , which is upregulated in the subset of proliferative Müller glia that will undergo neurogenesis upon damage. Interestingly, Ascl1 is not upregulated in mammalian Müller glia in an injury model, but in a conditional Ascl1 gain-of-function transgenic line, the increase in Ascl1 expression can induce new neurogenesis in mice (Pollak et al., 2013; Ueki et al., 2015) . However, this process is only efficient in young and not old animals (Jorstad et al., 2017) . One reason may be that Ascl1 target genes are in condensed chromatin and are not accessible, and indeed, the overexpression of Ascl1 along with exposure to an HDAC inhibitor, which de-condenses chromatin, can induce new neurogenesis in older animals (Jorstad et al., 2017) . However, this new neurogenesis does not include the derivation of new photoreceptors, which are often the cells that degenerate in retinal degenerative diseases, suggesting that additional studies are required to identify the conditions that can allow new photoreceptor genesis in older mammals. When retinal damage is induced by neurotoxic injury, transfection of bHLH transcription factors promotes the differentiation of Müller glia into progenitors, which then differentiate into other retinal cells types to replace those that are lost. In this model, co-expression of Neurod1 with Pax6 promotes differentiation into amacrine cells, while co-expression of Neurod4 and Pax6 promotes differentiation into both amacrine cells and horizontal cells (Ooto et al., 2004 ).
Summary and future perspectives
While developmental biologists may have paved the way for the field of direct neuronal reprogramming, the attempts to induce neurons using developmental approaches have highlighted developmental questions that still need to be resolved. Proneural genes have emerged as critical architects of neuronal reprogramming (Wilkinson et al., 2013) . However, they are not active in all contexts; Ascl1 is a potent neuronal reprogramming factor in fibroblasts (Caiazzo et al., 2011; Kim et al., 2011; Pang et al., 2011; Pfisterer et al., 2011; Son et al., 2011; Vierbuchen et al., 2010) , hepatocytes (Marro et al., 2011) , cardiomyocytes (Chuang et al., 2017) , astrocytes (Rivetti di Val Cervo et al., 2017) and pluripotent cells (Yang et al., 2017) , and not in the adult neocortex (Grande et al., 2013) , hippocampus and spinal cord (Jessberger et al., 2008; Ohori et al., 2006) . Similarly, Neurog2 is used less often for neuronal reprogramming as it must be combined with other signals to become a potent lineage converter . Thus, by better understanding how proneural genes are regulated, they can be more efficiently used in regenerative medicine.
The transcription factors that are co-expressed with bHLH factors such as Ascl1 and Neurog2 alter the resulting subtype of the induced neuron. These changes are likely a result of an altered epigenetic landscape within the cell. A better understanding of how factors upstream of proneural genes regulate epigenetic status will allow for a better refinement of the strategies used for inducing specific neuronal subtypes. Developmental biologists thus still have important questions to answer before specific neuronal subtypes can be consistently and efficiently produced. The reprogramming of astrocytes is a promising approach, as it holds the benefit of mobilizing cells in vivo to repair damage to the brain. However, astrocyte reprogramming still faces the same ethical hurdles of introducing genetic material into human patients and the potential for tumorigenic effects.
